X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1040) 1040
Publication (83) 83
Book / eBook (18) 18
Book Chapter (9) 9
Conference Proceeding (9) 9
Newspaper Article (8) 8
Book Review (6) 6
Dissertation (3) 3
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (681) 681
cardiac & cardiovascular systems (602) 602
female (477) 477
male (474) 474
index medicus (459) 459
middle aged (407) 407
aged (400) 400
mortality (292) 292
treatment outcome (222) 222
abridged index medicus (215) 215
risk factors (171) 171
heart attacks (170) 170
myocardial infarction - mortality (150) 150
prognosis (149) 149
myocardial infarction - therapy (136) 136
stroke (136) 136
electrocardiography (133) 133
myocardial infarction (133) 133
heart attack (128) 128
acute coronary syndromes (122) 122
heart failure (122) 122
peripheral vascular disease (122) 122
care and treatment (119) 119
acute myocardial-infarction (118) 118
medicine, general & internal (115) 115
thrombolytic therapy (115) 115
cardiovascular (112) 112
medicin och hälsovetenskap (112) 112
medical and health sciences (111) 111
myocardial infarction - drug therapy (110) 110
drug therapy (108) 108
therapy (108) 108
atrial fibrillation (106) 106
cardiac patients (105) 105
kardiologi (100) 100
cardiac and cardiovascular systems (99) 99
risk (99) 99
clinical trials (98) 98
patient outcomes (96) 96
research (95) 95
cardiology (94) 94
anticoagulants (91) 91
time factors (90) 90
trial (90) 90
percutaneous coronary intervention (89) 89
management (88) 88
analysis (87) 87
outcomes (87) 87
reperfusion (87) 87
coronary heart disease (85) 85
risk assessment (83) 83
clinical medicine (80) 80
follow-up studies (79) 79
warfarin (79) 79
double-blind method (76) 76
randomized controlled trials as topic (75) 75
adult (74) 74
cardiovascular disease (73) 73
hospitalization (72) 72
klinisk medicin (71) 71
angioplasty (70) 70
fibrinolytic agents - therapeutic use (69) 69
anticoagulants - therapeutic use (67) 67
myocardial-infarction (67) 67
prospective studies (65) 65
hematology (64) 64
patients (64) 64
prevention (63) 63
medical research (62) 62
survival (62) 62
angioplasty, balloon, coronary (59) 59
studies (57) 57
survival analysis (57) 57
aspirin (56) 56
stroke - prevention & control (56) 56
aged, 80 and over (55) 55
atrial fibrillation - drug therapy (55) 55
myocardial infarction - physiopathology (55) 55
clinical outcomes (54) 54
myocardial infarction - diagnosis (54) 54
registries (54) 54
united states (54) 54
cardiac arrhythmia (53) 53
unstable angina (53) 53
multivariate analysis (52) 52
atrial fibrillation - complications (51) 51
guidelines (50) 50
primary angioplasty (50) 50
proportional hazards models (49) 49
retrospective studies (49) 49
health aspects (47) 47
incidence (47) 47
heart (46) 46
ischemia (46) 46
transluminal angioplasty (46) 46
apixaban (45) 45
coronary vessels (45) 45
thrombolysis (45) 45
heart failure - drug therapy (44) 44
heart failure - mortality (43) 43
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Engineering & Comp. Sci. - Stacks (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Providence Healthcare - Stacks (2) 2
Online Resources - Online (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ANNALS OF INTERNAL MEDICINE, ISSN 0003-4819, 02/2019, Volume 170, Issue 4, pp. JC23 - JC23
Journal Article
LANCET, ISSN 0140-6736, 10/2015, Volume 386, Issue 10005, pp. 1737 - 1737
Journal Article
European Heart Journal, ISSN 0195-668X, 05/2013, Volume 34, Issue 20, pp. 1475 - 1480
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2019, Volume 380, Issue 16, pp. 1509 - 1524
Journal Article
The Lancet, ISSN 0140-6736, 09/2003, Volume 362, Issue 9386, pp. 772 - 776
Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of patients with chronic heart failure (CHF). A substantial proportion of patients, however,... 
CONTEMPORARY MANAGEMENT | MORTALITY | MEDICINE, GENERAL & INTERNAL | MORBIDITY | RECEPTOR BLOCKERS | IMPROVEMENT | DYSFUNCTION | PROGRAM | ENALAPRIL | RANDOMIZED TRIAL | ANGIOEDEMA | Ventricular Dysfunction, Left - epidemiology | Cough - chemically induced | Follow-Up Studies | Angiotensin Receptor Antagonists | Cardiac Output, Low - epidemiology | Comorbidity | Humans | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use | Hypotension - chemically induced | Heart Failure - drug therapy | Ventricular Dysfunction, Left - drug therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Kidney Diseases - chemically induced | Female | Tetrazoles - therapeutic use | Aged | Cardiac Output, Low - drug therapy | Heart Failure - epidemiology | Benzimidazoles - therapeutic use | Heart failure | Evaluation | Drug therapy | Candesartan | Angiotensin II receptor blockers | Disease management | Clinical outcomes | Morbidity | Heart | Renal function | Heart attacks | Laboratories | Angioplasty | Beta blockers | Anaphylaxis | Dyspnea | Enzyme inhibitors | Motivation | Peptidyl-dipeptidase A | Patient safety | Heart diseases | Drug dosages | Edema | Enzymes | Stroke | Mortality | Angina pectoris | Patients | Hypotension | Cough | Intolerance | Inhibitors | Converting | Angiotensin | Diabetes | Ventricle | Cardiovascular diseases | ACE inhibitors | Ejection
Journal Article
LANCET, ISSN 0140-6736, 07/2015, Volume 386, Issue 9990, pp. 248 - 248
Journal Article
American Heart Journal, ISSN 0002-8703, 2012, Volume 163, Issue 5, pp. 844 - 850.e1
Background Cardiovascular risk models remain incomplete. Small-molecule metabolites may reflect underlying disease and, as such, serve as novel biomarkers of... 
Cardiovascular | NRI | Global Registry of Acute Coronary Events | myocardial infarction | net reclassification improvement | interquartile range | IQR | IDI | MURDOCK CV | PCA | Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis Cardiovascular Study | GRACE | integrated discrimination index | hazard ratio | confidence interval | principal component analysis | IMPROVEMENTS | ASSOCIATION | CARDIAC & CARDIOVASCULAR SYSTEMS | Multivariate Analysis | Predictive Value of Tests | Confidence Intervals | Age Distribution | Prevalence | Prognosis | Blood Chemical Analysis | Humans | Middle Aged | Cardiac Catheterization - statistics & numerical data | Male | Lipids - blood | Cardiac Catheterization - methods | Cardiovascular Diseases - epidemiology | Adult | Female | Retrospective Studies | Cardiovascular Diseases - diagnosis | Severity of Illness Index | Cardiovascular Diseases - metabolism | Risk Assessment | Coronary Artery Disease - metabolism | Biomarkers - blood | Metabolomics - methods | Stroke Volume | Analysis of Variance | Coronary Artery Disease - diagnosis | Survival Analysis | Sex Distribution | Coronary Artery Disease - epidemiology | Cohort Studies | Medical research | Metabolites | Cardiac patients | Medicine, Experimental | Disease susceptibility | Coronary heart disease | Heart attack | Risk factors | Cardiovascular disease | Heart attacks | Cardiology | Mortality
Journal Article
The Lancet, ISSN 0140-6736, 09/2003, Volume 362, Issue 9386, pp. 767 - 771
Angiotensin II type 1 receptor blockers have favourable effects on haemodynamic measurements, neurohumoral activity, and left-ventricular remodelling when... 
RECEPTOR BLOCKER | ACE-INHIBITORS | MEDICINE, GENERAL & INTERNAL | FORMING PATHWAYS | THERAPY | MANAGEMENT | GUIDELINES | ENALAPRIL | Follow-Up Studies | Angiotensin Receptor Antagonists | Cardiac Output, Low - epidemiology | Humans | Male | Ventricular Dysfunction, Left - mortality | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Cardiovascular Diseases - mortality | Placebos | Adult | Female | Cardiac Output, Low - drug therapy | Drug Therapy, Combination | Heart Failure - epidemiology | Benzimidazoles - therapeutic use | Heart Failure - mortality | Ventricular Dysfunction, Left - epidemiology | Drug Administration Schedule | Comorbidity | Treatment Outcome | Hospitalization | Antihypertensive Agents - therapeutic use | Heart Failure - drug therapy | Ventricular Dysfunction, Left - drug therapy | Cardiac Output, Low - mortality | Adolescent | Tetrazoles - therapeutic use | Heart failure | Evaluation | Drug therapy | Candesartan | Angiotensin II receptor blockers | Cardiac arrhythmia | Disease management | Clinical outcomes | Placebo effect | Heart | Heart attacks | Laboratories | Angioplasty | Subgroups | Dyspnea | Enzyme inhibitors | Motivation | Peptidyl-dipeptidase A | Angiotensin II | Heart diseases | Drug dosages | Edema | Enzymes | Stroke | Mortality | Angina pectoris | Patients | Morbidity | Inhibitors | Converting | Angiotensin | Diabetes | Ventricle | Health risk assessment | ACE inhibitors | Ejection
Journal Article
EUROPEAN HEART JOURNAL, ISSN 0195-668X, 05/2016, Volume 37, Issue 20, pp. 1582 - 1590
Aims Atrial fibrillation (AF) is associated with an increased risk of stroke, which is currently estimated by clinical characteristics. The cardiac biomarkers... 
Stroke | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | Atrial fibrillation | APIXABAN | NATRIURETIC PEPTIDE | ANTICOAGULATION | Troponin | THERAPY | REDUCTION | Biomarkers | Risk score | THROMBOEMBOLIC EVENTS | STRATIFICATION | Natriuretic peptides | CARDIAC BIOMARKERS | INSIGHTS
Journal Article